- Home
- PTGX vs MANH Comparison
PTGX vs MANH Comparison
Compare PTGX & MANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | MANH |
|---|---|---|
| Founded | 2006 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.2B |
| IPO Year | 2016 | 1998 |
Fundamental Metrics
Financial Performance| Metric | PTGX | MANH |
|---|---|---|
| Price | $138.00 | $188.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 11 |
| Target Price | $108.23 | ★ $209.73 |
| AVG Volume (30 Days) | 593.6K | ★ 880.8K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.56 |
| EPS | 0.05 | ★ 1.67 |
| Revenue | N/A | ★ $131,300,000.00 |
| Revenue This Year | $874.25 | $8.10 |
| Revenue Next Year | N/A | $8.81 |
| P/E Ratio | $2,645.60 | ★ $112.12 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $50.49 | $119.06 |
| 52 Week High | $143.29 | $220.72 |
Technical Indicators
Market Signals| Indicator | PTGX | MANH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About MANH Manhattan Associates Inc.
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers worldwide.